Literature DB >> 32160015

Basement Membrane Remodeling Controls Endothelial Function in Idiopathic Pulmonary Arterial Hypertension.

Katharina Jandl1,2, Leigh M Marsh1, Julia Hoffmann1, Ayse Ceren Mutgan3, Oliver Baum4, Wilhelm Bloch5, Helene Thekkekara-Puthenparampil1, Dagmar Kolb6, Katharina Sinn1,7, Walter Klepetko7, Akos Heinemann2, Andrea Olschewski1,8, Horst Olschewski1,9, Grazyna Kwapiszewska1,3.   

Abstract

The extracellular matrix (ECM) increasingly emerges as an active driver in several diseases, including idiopathic pulmonary arterial hypertension (IPAH). The basement membrane (BM) is a specialized class of ECM proteins. In pulmonary arteries, the BM is in close contact and direct proximity to vascular cells, including endothelial cells. So far, the role of the BM has remained underinvestigated in IPAH. Here, we aimed to shed light on the involvement of the BM in IPAH, by addressing its structure, composition, and function. On an ultrastructural level, we observed a marked increase in BM thickness in IPAH pulmonary vessels. BM composition was distinct in small and large vessels and altered in IPAH. Proteoglycans were mostly responsible for distinction between smaller and larger vessels, whereas BM collagens and laminins were more abundantly expressed in IPAH. Type IV collagen and laminin both strengthened endothelial barrier integrity. However, only type IV collagen concentration dependently increased cell adhesion of both donor and IPAH-derived pulmonary arterial endothelial cells (PAECs) and induced nuclear translocation of mechanosensitive transcriptional coactivator of the hippo pathway YAP (Yes-activated protein). On the other hand, laminin caused cytoplasmic retention of YAP in IPAH PAECs. Accordingly, silencing of COL4A5 and LAMC1, respectively, differentially affected tight junction formation and barrier integrity in both donor and IPAH PAECs. Collectively, our results highlight the importance of a well-maintained BM homeostasis. By linking changes in BM structure and composition to altered endothelial cell function, we here suggest an active involvement of the BM in IPAH pathogenesis.

Entities:  

Keywords:  barrier function; extracellular matrix; laminin; type IV collagen; vascular remodeling

Year:  2020        PMID: 32160015     DOI: 10.1165/rcmb.2019-0303OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  IL-13 alleviates idiopathic pulmonary hypertension by inhibiting the proliferation of pulmonary artery smooth muscle cells and regulating macrophage infiltration.

Authors:  Ruda Wei; Liting Chen; Pengchuan Li; Chaoyang Lin; Qingshi Zeng
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.

Authors:  Danyan Su; Yanyun Huang; Dongli Liu; Yuqin Huang; Bingbing Ye; Suyuan Qin; Cheng Chen; Yusheng Pang
Journal:  Transl Pediatr       Date:  2022-05

3.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

4.  Hiding in Plain Sight: The Basement Membrane in Pulmonary Vascular Remodeling.

Authors:  Ananya Chakraborty; Vinicio A de Jesus Perez
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

Review 5.  The Glycobiology of Pulmonary Arterial Hypertension.

Authors:  Shia Vang; Phillip Cochran; Julio Sebastian Domingo; Stefanie Krick; Jarrod Wesley Barnes
Journal:  Metabolites       Date:  2022-04-01

6.  Dysfunctional ERG signaling drives pulmonary vascular aging and persistent fibrosis.

Authors:  Nunzia Caporarello; Jisu Lee; Tho X Pham; Dakota L Jones; Jiazhen Guan; Patrick A Link; Jeffrey A Meridew; Grace Marden; Takashi Yamashita; Collin A Osborne; Aditya V Bhagwate; Steven K Huang; Roberto F Nicosia; Daniel J Tschumperlin; Maria Trojanowska; Giovanni Ligresti
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

Review 7.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 8.  Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?

Authors:  Ayse Ceren Mutgan; Katharina Jandl; Grazyna Kwapiszewska
Journal:  Cells       Date:  2020-09-03       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.